Furthermore, RFA was reported to markedly increase the infiltration of intratumoral CD8+T lymphocytes and the number of antigen-specific CD8+T cells within the tumor microenvironment, also it could increase CD8+ effector T cell infiltration at residual tumor sites (18–20). This evidence concerns the gene CD8A and neoplasm.